Medicare Enrolled

Dr. Amor Mehta, MD

Neurology · Marlboro, NJ
Practice pattern: Remote Monitoring — Significant remote device monitoring activity
Speaking/Promotional
479 COUNTY ROAD 520, Marlboro, NJ 07746
7328565999
In practice since 2007 (19 years)
NPI: 1558566471 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mehta from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mehta? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mehta

Dr. Amor Mehta is a neurology specialist in Marlboro, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Mehta performed 1,864 Medicare services across 1,252 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mehta received a total of $94,205 from 54 pharmaceutical and/or device companies across 856 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mehta is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 19% volume in NJ $94,205 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,864
Medicare services
Top 19% in NJ for neurology
1,252
Unique beneficiaries
$275
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~98 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
643 $140 $369
Video EEG monitoring, 12-26 hours
Continuous monitoring of brain wave activity combined with video recording for 12 to 26 hours.
249 $952 $5,889
VEEG monitoring, 12-26 hours with review
This procedure involves monitoring brain wave activity along with video recording for 12 to 26 hours. A healthcare professional reviews the data and provides a report.
248 $164 $1,589
Continuous EEG brain wave monitoring
A test that records electrical activity in the brain over an extended period. It is used to monitor brain function continuously.
188 $193 $888
New patient office visit, complex (60-74 min) 142 $175 $524
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
141 $387 $989
Prolonged office E/M service, first 15 minutes
This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service.
136 $26 $288
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
79 $314 $988
Psychological test administration, first 30 minutes
A technician administers psychological or neuropsychological testing for the first 30 minutes.
38 $27 $200
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$94,205
Total received (2018-2024)
Avg $13,458/year across 7 years
Top 4% in NJ for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
856
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$68,365 (72.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$17,965 (19.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,875 (8.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$12,655
2023
$16,659
2022
$16,478
2021
$14,972
2020
$12,242
2019
$8,581
2018
$12,618

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
SK Life Science, Inc.
$8,361
UCB, Inc.
$2,908
ABBVIE INC.
$310
Neurelis, Inc.
$219
Medtronic, Inc.
$143
Lilly USA, LLC
$111
Aucta Pharmaceuticals, Inc.
$109
PFIZER INC.
$95
JAZZ PHARMACEUTICALS INC.
$70
Otsuka America Pharmaceutical, Inc.
$51
Lundbeck LLC
$50
Ceribell, Inc.
$49
Sumitomo Pharma America, Inc.
$43
Marinus Pharmaceuticals, Inc.
$32
Eisai Inc.
$17
Neos Therapeutics, LP
$17
SCILEX PHARMACEUTICALS INC.
$16
AQUESTIVE THERAPEUTICS, INC.
$15
ACADIA Pharmaceuticals Inc
$14
BIOCODEX, INC.
$14
Teva Pharmaceuticals USA, Inc.
$13
Top 3 companies account for 91.5% of 2024 payments
All-time payments by company (2018-2024) ›
SK Life Science, Inc.
$46,001
UCB, Inc.
$27,503
Sunovion Pharmaceuticals Inc.
$12,377
Neurelis, Inc.
$867
JAZZ PHARMACEUTICALS INC.
$809
ABBVIE INC.
$772
Amgen Inc.
$584
Teva Pharmaceuticals USA, Inc.
$560
AQUESTIVE THERAPEUTICS, INC.
$450
Eisai Inc.
$417
Lilly USA, LLC
$352
NEUROPACE, INC.
$298
Greenwich Biosciences, Inc.
$241
Supernus Pharmaceuticals, Inc.
$218
PFIZER INC.
$189
AbbVie Inc.
$171
Biohaven Pharmaceutical Holding Company Ltd.
$169
Sumitomo Pharma America, Inc.
$162
Medtronic, Inc.
$156
Allergan, Inc.
$154
LivaNova USA, Inc.
$152
EISAI INC.
$151
Lundbeck LLC
$144
IMPEL PHARMACEUTICALS INC.
$130
Aucta Pharmaceuticals, Inc.
$109
Aprecia Pharmaceuticals, LLC
$97
Biohaven Pharmaceuticals, Inc.
$96
Almatica Pharma LLC
$94
ACADIA Pharmaceuticals Inc
$71
Adamas Pharmaceuticals, Inc.
$65
Novartis Pharmaceuticals Corporation
$60
OWP Pharmaceuticals, Inc.
$57
GENZYME CORPORATION
$52
BioMarin Pharmaceutical Inc.
$51
Otsuka America Pharmaceutical, Inc.
$51
Ceribell, Inc.
$49
Marinus Pharmaceuticals, Inc.
$45
Medtronic USA, Inc.
$32
BIOCODEX, INC.
$26
Upsher-Smith Laboratories LLC
$17
Arbor Pharmaceuticals, Inc.
$17
Neos Therapeutics, LP
$17
PORTOLA PHARMACEUTICALS, INC.
$16
Novocure Inc.
$16
SCILEX PHARMACEUTICALS INC.
$16
Promius Pharma LLC
$15
Bayer HealthCare Pharmaceuticals Inc.
$15
Azurity Pharmaceuticals, Inc.
$15
Impax Laboratories, Inc.
$15
Alexion Pharmaceuticals, Inc.
$15
Egalet US Inc
$14
Assertio Therapeutics, Inc.
$14
Mallinckrodt LLC
$14
Bio Products Laboratory USA, Inc.
$9
Top 3 companies account for 91.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · AFINITOR · AIMOVIG · AJOVY · AMYVID · APTIOM · AUBAGIO · AUSTEDO · Adzenys XR-ODT · Aimovig · Austedo XR · BEVYXXA · Banzel · Betaseron · Brineura · Briviact · CAMBIA · COPAXONE · Cenobamate · DAYBUE · DIACOMIT · ELYXYB - CELECOXIB · EMGALITY · EPIDIOLEX · Epidiolex · Fintepla · Fycompa · GOCOVRI · GRALISE · Gammaplex · Horizant · LEMTRADA · LIBERVANT · Leqembi · Motpoly XR · NAPRELAN · NORTHERA · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · ONFI · OXTELLAR XR · Optune · PANZYGA · PAXLOVID · PERCEPT PC BRAINSENSE · POCKET EEG DEVICE · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · REXULTI · RNS Neurostimulator Kit · RYTARY · SOLIRIS · SPRIX · SUBVENITE · SYMPAZAN · Spritam · Subvenite · TROKENDI XR · Trudhesa · UBRELVY · VALTOCO · VISUALASE · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VYEPTI · Vimpat · XCOPRI · ZAVZPRET · ZTALMY · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (73%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for neurology in NJ.

Looking for a neurology specialist in Marlboro?
Compare neurologists in the Marlboro area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
212
Per 100K population
32.9
County median income
$122,727
Nearest hospital
BAYSHORE MEDICAL CENTER
5.5 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Mehta is a remote monitoring specialist, with above-average Medicare volume (top 19% in NJ), with speaking/promotional industry engagement in the top 4% of NJ peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Mehta experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Mehta performed 643 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mehta receive payments from pharmaceutical companies?
Yes. Dr. Mehta received a total of $94,205 from 54 companies across 856 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mehta's costs compare to other neurologists in Marlboro?
Dr. Mehta's average Medicare payment per service is $275. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mehta) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →